Synergy Pharmaceuticals Inc fka SGYPQ

[Snackman]

Investors Scour Big Pharma M&A Scene for Next Big Takeover
By
James Passeri
Follow
| Jul 21, 2016 | 2:58 PM EDT

...Meanwhile, shares of Synergy Pharmaceuticals (SGYP) -- a popular takeover prospect last fall -- jumped about 5% as it appears more likely that suitors will come knocking to obtain the drugmaker, especially as its chief product, gastrointestinal therapy plecanatide, continues to strive for FDA approval as it prepares to release Phase III trial data.

Real Money Pro's Bret Jensen -- who recommended buying Relypsa stock in April, calling it "insanely low-priced given its fundamentals" -- said in a phone interview Thursday that the Relypsa takeover may not be large enough to set off a significant takeover wave among large-cap companies, but noted, "I do think you're going to see some smaller deals," and that "Synergy would be one of those names right up that alley."